Comments
Avastin delays progression of ovarian cancer
02.06.2012. | CHICAGO (Reuters) - Adding cancer drug Avastin to standard chemotherapy doubled the length of time a certain group of advanced ovarian cancer patients lived without their disease getting worse, according to results of a clinical trial....
